Group photo (IMAGE)

The University of Hong Kong

Group photo

Caption

A research team from HKUMed developed a photoactivatable prodrug nanomedicine for age-related macular degeneration (AMD) therapy. The research team members include: (from left) Dr Li Jia, Xu Shuting, Dr Wang Weiping, Dr Fan Ni, and Long Kaiqi.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.